TransUnion [TRU] vs CME [CME] Detailed Stock Comparison

TransUnion

NYSE
Loading...

CME

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: TransUnion wins in 5 metrics, CME wins in 15 metrics, with 0 ties. CME appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTransUnionCMEBetter
P/E Ratio (TTM)44.9125.62CME
Price-to-Book Ratio3.743.43CME
Debt-to-Equity Ratio115.6713.60CME
PEG Ratio18.421.64CME
EV/EBITDA14.9321.35TransUnion
Profit Margin (TTM)8.63%58.59%CME
Operating Margin (TTM)28.33%66.87%CME
EBITDA Margin (TTM)28.33%66.87%CME
Return on Equity8.89%13.61%CME
Return on Assets (TTM)4.94%1.74%TransUnion
Free Cash Flow (TTM)$516.70M$3.60BCME
Dividend Yield0.38%4.30%CME
1-Year Return-26.13%17.93%CME
Price-to-Sales Ratio (TTM)3.8514.83TransUnion
Enterprise Value$21.08B$97.06BCME
EV/Revenue Ratio4.9515.09TransUnion
Gross Profit Margin (TTM)59.33%86.90%CME
Revenue per Share (TTM)$22$18TransUnion
Earnings per Share (Diluted)$1.87$10.33CME
Beta (Stock Volatility)1.640.43CME
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

TransUnion vs CME Stock Performance Analysis

Loading Price Chart...

TransUnion
CME
TransUnion Stock Overview | CME Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TransUnion5.21%-9.21%-10.10%-15.58%2.60%-15.80%
CME-0.29%-2.08%-1.74%-4.35%-1.38%13.73%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TransUnion-26.13%33.95%-13.32%209.36%211.23%211.23%
CME17.93%55.76%56.23%199.74%404.33%294.38%

News Based Sentiment: TransUnion vs CME

TransUnion

News based Sentiment: MIXED

TransUnion delivered a strong earnings report, but the announcement of FICO's direct licensing program and a significant data breach created substantial headwinds. The mixed analyst reactions and institutional investor activity reflect the uncertainty surrounding the company's near-term prospects, making October a pivotal month.

View TransUnion News Sentiment Analysis

CME

News based Sentiment: POSITIVE

CME Group is demonstrating strong financial performance and strategic growth, particularly in the rapidly expanding cryptocurrency market. The upcoming earnings report and new product launches represent key catalysts for continued positive momentum, despite some mixed signals from institutional investors.

View CME News Sentiment Analysis

Performance & Financial Health Analysis: TransUnion vs CME

MetricTRUCME
Market Information
Market Cap i$16.38B$96.97B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,816,8101,751,020
90 Day Avg. Volume i1,935,5631,905,747
Last Close$77.34$264.67
52 Week Range$66.38 - $113.17$213.94 - $290.79
% from 52W High-31.66%-8.98%
All-Time High$125.35 (Sep 06, 2021)$290.79 (Jun 02, 2025)
% from All-Time High-38.30%-8.98%
Growth Metrics
Quarterly Revenue Growth0.07%0.10%
Quarterly Earnings Growth1.28%0.16%
Financial Health
Profit Margin (TTM) i0.09%0.59%
Operating Margin (TTM) i0.28%0.67%
Return on Equity (TTM) i0.09%0.14%
Debt to Equity (MRQ) i115.6713.60
Cash & Liquidity
Book Value per Share (MRQ)$22.48$77.13
Cash per Share (MRQ)$3.14$5.82
Operating Cash Flow (TTM) i$831.00M$4.20B
Levered Free Cash Flow (TTM) i$549.89M$2.92B
Dividends
Last 12-Month Dividend Yield i0.38%4.30%
Last 12-Month Dividend i$0.32$11.85

Valuation & Enterprise Metrics Analysis: TransUnion vs CME

MetricTRUCME
Price Ratios
P/E Ratio (TTM) i44.9125.62
Forward P/E i18.4225.52
PEG Ratio i18.421.64
Price to Sales (TTM) i3.8514.83
Price to Book (MRQ) i3.743.43
Market Capitalization
Market Capitalization i$16.38B$96.97B
Enterprise Value i$21.08B$97.06B
Enterprise Value Metrics
Enterprise to Revenue i4.9515.09
Enterprise to EBITDA i14.9321.35
Risk & Other Metrics
Beta i1.640.43
Book Value per Share (MRQ) i$22.48$77.13

Financial Statements Comparison: TransUnion vs CME

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TRUCME
Revenue/Sales i$1.04B$1.64B
Cost of Goods Sold i$411.60M$206.70M
Gross Profit i$625.20M$1.44B
Research & Development iN/AN/A
Operating Income (EBIT) i$170.70M$1.11B
EBITDA i$304.10M$476.30M
Pre-Tax Income i$100.60M$1.24B
Income Tax i$29.90M$288.60M
Net Income (Profit) i$70.70M$956.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TRUCME
Cash & Equivalents i$679.50M$1.41B
Total Current Assets i$1.80B$123.45B
Total Current Liabilities i$1.06B$121.42B
Long-Term Debt i$5.12B$3.42B
Total Shareholders Equity i$4.32B$27.03B
Retained Earnings i$2.36B$4.69B
Property, Plant & Equipment i$55.80M$371.20M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TRUCME
Operating Cash Flow i$249.20M$838.30M
Capital Expenditures iN/A$-14.20M
Free Cash Flow i$136.90M$1.10B
Debt Repayment i$-916.10M$-750.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTRUCME
Shares Short i5.61M4.63M
Short Ratio i2.852.42
Short % of Float i0.03%0.01%
Average Daily Volume (10 Day) i1,816,8101,751,020
Average Daily Volume (90 Day) i1,935,5631,905,747
Shares Outstanding i194.90M359.61M
Float Shares i194.47M358.80M
% Held by Insiders i0.00%0.00%
% Held by Institutions i1.03%0.92%

Dividend Analysis & Yield Comparison: TransUnion vs CME

MetricTRUCME
Last 12-Month Dividend i$0.32$11.85
Last 12-Month Dividend Yield i0.38%4.30%
3-Year Avg Annual Dividend i$0.34$10.10
3-Year Avg Dividend Yield i0.14%0.91%
3-Year Total Dividends i$1.02$30.30
Ex-Dividend DateFeb 27, 2025Sep 09, 2025